HuagongsheHuagongshe Chemistry Print Report · For research reference only
Levodopa → Carbidopa
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Levodopa | HCID 6047 | — |
| Reactant | Carbidopa-levodopa mixt. | HCID 104778 | — |
| Product | Carbidopa | HCID 34359 | — |
Reaction Steps
The in vitro dissolution profile of levodopa-carbidopa extended release capsules (from Example 3E), containing 200 mg levodopa and 50 mg carbidopa was obtained under simulated gastric conditions. The dissolution tests were performed in 900 mL of a 0.1 N HCl-pH 1.2 solution in a USP II apparatus at a temperature of 37° C. The paddle speed was set at 50 rpm. Samples of dissolution media were collected at predetermined intervals and analyzed by HPLC. The dissolution profiles of levodopa and carbidopa obtained from HPLC analysis are shown in FIG. 13.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08491929B2 |
| Source dataset | uspto-grants-2013_07 |
| ORD ID | ord-63192a2fe1f54bafafb08780368c4579 |
| Source note | uspto-grants-2013_07 |